Production of Russian COVID-19 Vaccine May Be Organized in Germany

26 November 2020

GMP News

The Russian Direct Investment Fund (RDIF) is looking at possible production of the Russian Sputnik V anti-coronavirus vaccine in Germany, RDIF’s CEO Kirill Dmitriev said.

He noted that Hungary is one of the first European countries to demonstrate interest to the Russian vaccine.

“This week we expect a big delegation from France to visit Moscow. We are working with a big number of European countries. We will probably manufacture our vaccine in Germany,” he said in an interview with the Rossiya-24 television channel.

According to Dmitriev, Russia will continue cooperation with Europe on issues with the vaccine production, despite the problems stemming from political gaps. “The European Union will obviously be a difficult market, regrettably, due to political reasons,” he said. “But we will continue to work with the European Union. On October 22, we filed a request for approval with the European Medical Association.”

Source

Print

Shareholders

Read more

Pipeline

Read more

Media Center

Read more